UBS AM
PLSE icon

UBS AM’s Pulse Biosciences PLSE Stock Holding History

UBS AM’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$855K Sell
30,817
-1,003
-3% -$23.7K ﹤0.01% 2390
2026
Q1 		$687K Buy
31,820
+1,119
+4% +$20.7K ﹤0.01% 2465
2025
Q4 		$422K Buy
30,701
+225
+0.7% +$3.51K ﹤0.01% 2356
2025
Q3 		$539K Sell
30,476
-17,855
-37% -$282K ﹤0.01% 2148
2025
Q2 		$729K Buy
48,331
+11,800
+32% +$196K ﹤0.01% 2443
2025
Q1 		$588K Sell
36,531
-1,777
-5% -$33.1K ﹤0.01% 2463
2024
Q4 		$667K Buy
38,308
+4,773
+14% +$84.1K ﹤0.01% 2501
2024
Q3 		$588K Buy
+33,535
New +$572K ﹤0.01% 2604

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

UBS AM's PLSE Position: Q2 2026 in Review

UBS AM reduced its Pulse Biosciences (PLSE) stake by 3.2% in Q2 2026, selling an estimated $23.7K and leaving 30,817 shares worth $855K. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

UBS AM first reported a position in PLSE in Q3 2024 and has held it in 8 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • UBS AM held 30,817 shares of Pulse Biosciences worth $855K as of Q2 2026.
  • UBS AM sold 1,003 Pulse Biosciences shares in Q2 2026, an estimated $23.7K.
  • Pulse Biosciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2390 holding.
  • UBS AM first reported a position in Pulse Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.